Skip to content
Disclosery

EXANE DERIVATIVES: FOX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on FOX, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 61 FOX shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 61 shares
    Change vs previous 13F -1,851 shares

    <0.01% of the 13F portfolio, value $1,811.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,912 shares
    Change vs previous 13F -140 shares

    0.02% of the 13F portfolio, value $69,363.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,052 shares
    Change vs previous 13F +2,029 shares

    0.02% of the 13F portfolio, value $70,319.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 23 shares
    Change vs previous 13F -278 shares

    <0.01% of the 13F portfolio, value $854.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 301 shares
    Change vs previous 13F -1,821 shares

    <0.01% of the 13F portfolio, value $10,225.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,122 shares
    Change vs previous 13F -564 shares

    0.02% of the 13F portfolio, value $74,118.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,686 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $77,568.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).